CUSIP 880881107COM430Q4 2025
74 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 8.19M | $331.05M |
| 2 | Morgan Stanley | 7.95M | $321.00M |
| 3 | Adage Capital Partners Gp, L.L.C. | 5.55M | $224.22M |
| 4 | Vanguard Group Inc | 5.52M | $223.17M |
| 5 | Vivo Capital, LLC | 5.35M | $216.02M |
| 6 | Vestal Point Capital, LP | 4.50M | $181.80M |
| 7 | Janus Henderson Group PLC | 3.38M | $136.50M |
| 8 | Citadel Advisors LLC | 3.17M | $127.93M |
| 9 |
| 4 | Feb 12, 2026 | Soleus Capital Master Fund, L.P. | 13G/A | 0.2% | 591.1K | SEC |
| 5 | Feb 12, 2026 | Adage Capital Management, L.P. | 13G | 5.1% | 5.55M | SEC |
| 6 | Nov 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 5.70M | SEC |
| 7 | Nov 5, 2025 | Orbimed Advisors LLC | 13D/A | 4.8% | — | SEC |
| 8 | Oct 31, 2025 | The Vanguard Group | 13G | 5.2% | 4.56M | SEC |
| 9 | Sep 16, 2025 | Commodore Capital LP | 13G | 11.0% | 4.65M | SEC |
| 10 | Aug 14, 2025 | Deep Track Capital, LP | 13G/A | 8.6% | 7.50M | SEC |
See the full Schedule 13D/13G history for Terns Pharmaceuticals Inc.
Unlock full history| 3.05M |
| $123.03M |
| 10 | Holocene Advisors, LP | 2.78M | $112.13M |